• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

RealTalk MS

  • Home
  • Past Episodes
  • Videos
  • About RealTalk MS
  • Press Kit
  • Contact Us

Past Podcast Episodes

Episode 241: American Academy of Neurology Annual Meeting Recap with Prof. Xavier Montalban



I spent last week attending the American Academy of Neurology (AAN) Annual Meeting and in this week's episode of RealTalk MS, I'm sharing an overview of what I saw and what I heard.

Each year at the AAN meeting, the American Academy of Neurology and the National MS Society award the John Dystel Prize for MS Research. Joining me on today's podcast is this year's recipient of the Dystel Prize, Professor Xavier Montalban.

We're also talking about how the COVID-19 pandemic has affected MS research and clinical care.

We're sharing encouraging news about two potential disease-modifying therapies.

And we'll share some of the over-arching themes that kept popping up in a number of different meetings, presentations, and conversations during the AAN annual meeting.

We have a lot to talk about! Are you ready for RealTalk MS??!


The impact of the pandemic on MS research and clinical care   :53

Results of Phase 2 extension study show Evobrutinib effective in reducing relapse rates in relapsing forms of MS   4:53

Results of Ublituximab Phase 3 post-hoc analyses announced    7:16

Dr. Stephen Hauser receives the Scientific Breakthrough Award  9:25

The importance of making complex science easy to understand for people affected by MS  10:29

The importance of increasing clinical trial participation among members of minority communities  12:48

The importance of caring for the caregiver  14:04

John Dystel Prize for MS Research awarded to Prof. Xavier Montalban  15:40

My conversation with John Dystel Prize recipient Professor Xavier Montalban  16:25

Share this episode  24:51

Have you downloaded the RealTalk MS app?   25:12


SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/241

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jonstrum@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!


LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society COVID-19 Vaccine Guidance for People Living with MS
https://www.nationalmssociety.org/coronavirus-covid-19-information/multiple-sclerosis-and-coronavirus/covid-19-vaccine-guidance

Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

Download the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200

Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk

Give RealTalk MS a rating and review
http://www.realtalkms.com/review


Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 241
Guests: Professor Xavier Montalban

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS

Privacy Policy

 

Filed Under: Uncategorized

Episode 240: Hypnosis and MS with Dr. Mark Jensen


Research has shown that hypnosis is an effective treatment for managing chronic pain, including pain associated with MS. 

My guest, Dr. Mark Jensen, is a Professor and Vice-Chair of the Department of Rehabilitation Medicine at the University of Washington. Dr. Jensen has devoted his career to developing effective treatments for pain and is an expert on hypnotic interventions.

Hypnosis for chronic pain management

We're also talking about a research team that may have learned how to successfully penetrate the blood-brain barrier (and why that could be great news for people living with MS!).

We'll share the results of a 10-year study in France that showed very positive outcomes for people living with highly active relapsing-remitting MS.

We'll tell you about 66 research projects that have just been funded by the MS Society of Canada.

And we'll share results from a survey that identify pandemic-specific depression and anxiety among people living with MS.

We have a lot to talk about! Are you ready for RealTalk MS??!


Researchers may have found a way through the blood- brain barrier   1:17

10-year study reveals surprising results   4:19

MS Society of Canada announces funding for 66 research projects    8:07

Researchers identify pandemic-related depression among people living with MS  9:11

Dr. Mark Jensen discusses treating MS-related chronic pain with hypnosis  12:43

Share this episode  30:58

Have you downloaded the RealTalk MS app?   31:19


SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/240

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jonstrum@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!


LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society COVID-19 Vaccine Guidance for People Living with MS
https://www.nationalmssociety.org/coronavirus-covid-19-information/multiple-sclerosis-and-coronavirus/covid-19-vaccine-guidance

STUDY: Endothelial Unc5B Controls Blood-Brain Barrier Integrity
https://www.nature.com/articles/s41467-022-28785-9

STUDY: Ten-Year Follow-Up After Mitoxantrone Induction For Early Highly Active Relapsing-Remitting Multiple Sclerosis: An Observational Study of 100 Consecutive Patients
https://sciencedirect.com/science/articles/abs/pii/5003578722000431

MS Society of Canada Research Funding Announcement
https://mssociety.ca/information-for-researchers/funding-announcements

National MS Society MS Navigator Contact Info
Phone: (800) 344-4867
Email: contactusnmss@nmss.org

Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

Download the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200

Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk

Give RealTalk MS a rating and review
http://www.realtalkms.com/review


Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 240
Guests: Dr. Mark Jensen

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS

Privacy Policy

Filed Under: Uncategorized

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 94
  • Page 95
  • Page 96
  • Page 97
  • Page 98
  • Interim pages omitted …
  • Page 228
  • Go to Next Page »

Primary Sidebar

ARE YOU ON OUR MAILING LIST?

Sign up to receive email updates from RealTalk MS. You’ll get a personal advance heads-up about every upcoming podcast episode.

And P.S. — We promise to keep your private information private! We won’t sell it, trade it, or share it.

DOWNLOAD THE APP!

It’s the easiest way to connect with the RealTalk MS podcast. You’ll never miss another episode.

AND…we’re sharing free bonus content available ONLY in the RealTalk MS app.

Download the FREE RealTalk MS app today. It’s your VIP pass to the RealTalk MS community.

Follow RealTalk MS!


Connect With Us

  • Email
  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter
  • YouTube

Copyright © 2025 RealTalk MS